Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy

Recombinant human leptin (metreleptin) improves glycaemia and hypertriglyceridaemia in patients with generalized lipodystrophy; antibody development with in vitro neutralizing activity has been reported. We aimed to characterize antimetreleptin antibody development, including in vitro neutralizing activity.

[1]  J. Friedman.  20 years of leptin: leptin at 20: an overview. , 2014, The Journal of endocrinology.

[2]  J. Heilig,et al.  Differentiation and quantification of endogenous and recombinant-methionyl human leptin in clinical plasma samples by immunocapture/mass spectrometry. , 2012, Journal of pharmaceutical and biomedical analysis.

[3]  N. Chirmule,et al.  Measurement of Anti-Erythropoiesis-Stimulating Agent IgG4 Antibody as an Indicator of Antibody-Mediated Pure Red Cell Aplasia , 2012, Clinical and Vaccine Immunology.

[4]  C. Procaccini,et al.  Leptin as an immunomodulator. , 2012, Molecular aspects of medicine.

[5]  J. Chan,et al.  Clinical effects of long-term metreleptin treatment in patients with lipodystrophy. , 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[6]  A. Garg.  Lipodystrophies: Genetic and Acquired Body Fat Disorders , 2011 .

[7]  Christine J. Bryson,et al.  Immunogenicity of protein therapeutics: The key causes, consequences and challenges. , 2010, Self/nonself.

[8]  G. Sebag,et al.  Resistance to leptin-replacement therapy in Berardinelli-Seip congenital lipodystrophy: an immunological origin. , 2010, European journal of endocrinology.

[9]  J. Chan,et al.  Clinical classification and treatment of congenital and acquired lipodystrophy. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[10]  E. Ravussin,et al.  Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy , 2009, Obesity.

[11]  Christian Weyer,et al.  Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies , 2008, Proceedings of the National Academy of Sciences.

[12]  G. Sebag,et al.  Metabolic Correction Induced by Leptin Replacement Treatment in Young Children With Berardinelli-Seip Congenital Lipoatrophy , 2007, Pediatrics.

[13]  Dennis D. Kim,et al.  Immunogenicity of xenopeptide hormone therapies , 2006, Peptides.

[14]  P. Gorden,et al.  Long-term efficacy of leptin replacement in patients with generalized lipodystrophy. , 2005, Diabetes.

[15]  R. Krauss,et al.  Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Garg.  Acquired and inherited lipodystrophies. , 2004, The New England journal of medicine.

[17]  Y. Matsuzawa,et al.  Serum adiponectin and leptin levels in patients with lipodystrophies. , 2004, The Journal of clinical endocrinology and metabolism.

[18]  Graham M Lord,et al.  Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. , 2002, The Journal of clinical investigation.

[19]  M. Reitman,et al.  Leptin-replacement therapy for lipodystrophy. , 2002, The New England journal of medicine.

[20]  K. Fujioka,et al.  Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. , 1999, JAMA.

[21]  M. Nicolson,et al.  Altered Cell Surface Expression and Signaling of Leptin Receptors Containing the fatty Mutation* , 1998, The Journal of Biological Chemistry.

[22]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[23]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[24]  P. Gorden,et al.  Efficacy of leptin therapy in the different forms of human lipodystrophy , 2009, Diabetologia.

[25]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.